Dr. Jan Patterson, Infectious Diseases, was interviewed about the experimental antibody IV therapy for COVID-19, bamlanivimab, that received emergency authorization from the FDA.
Newsroom
Dr. Jan Patterson, Infectious Diseases, was interviewed about the experimental antibody IV therapy for COVID-19, bamlanivimab, that received emergency authorization from the FDA.